HERCEPTIN Pages on BioPortfolio:

Biotechnology News HERCEPTIN Search
11 Nov 2009 ... Documents 1-25 out of 263 found. Current Search: herceptin: 263 ... Matching: herceptin, Find similar documents ...
http://www.bioportfolio.co.uk/HERCEPTIN-news.htm...

BioPortfolio - Herceptin
Herceptin - BioPortfolio - Indepth. ... Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent
...
http://www.bioportfolio.com/indepth/Herceptin.html...

BioPortfolio - Monogram Biosciences, Inc. - Monogram Announces ...
metastatic breast cancer who were treated with Herceptin. ... Herceptin therapy by IHC or FISH testing, with most having been selected by IHC performed in a ...
http://www.bioportfolio.com/news/Monogram_Announces_Presenta...

Biotechnology News heart herceptin. mcdonald. canadian ...
Documents 1-10 out of 1000 found. Current Search: heart: 10734, herceptin: 249, mcdonald: 340, canadian: 4720, cardiovascular: 3923, eject: 73, failur: 3613 ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

BioPortfolio Limited Global Biotech Market Analysis and Forecasts ...
4.10.2 Development of Herceptin 4.11 Epogen Sales Outlook from 2008 Onwards .... Figure 4.11 World Revenues ($m) for Herceptin 2008-2013, 2018 & 2023 ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_602.html...

Biotechnology News cancer her2. 965. 229. recurr. overexpress ...
Study finds small HER2-positive tumors need Herceptin CHICAGO - Nov. 6, 2009 - Early-stage breast cancer patients with small HER2 positive tumors are at ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

Competitor Analysis: Her2 Receptor Antagonists
The commercial success of Herceptin (trastuzumab) with 2008 sales US$ 4.8 bln and ... Therapeutic Her2 Vaccines; Herceptin Pipeline; Selective Her2 Receptor
...
http://www.bioportfolio.com/cgi-bin/acatalog/Competitor-Anal...

BioPortfolio Biotechnology BioNews : live article
"Building upon the foundation laid by Rituxan, Herceptin, Avastin and Tarceva, we hope that these new investigational molecules may one day become part of ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

Launching Next Generation Oncology Products: Evolving Strategies ...
... investments in oncology R&D, in an effort to emulate the success of new targeted therapies such as Herceptin, Avastin, Glivec, Nexavar and Erbitux. ...
http://www.bioportfolio.com/cgi-bin/acatalog/Launching-Next-...

Results from other life science and pharmaceutical sites:

Trastuzumab - Wikipedia, the free encyclopedia
Trastuzumab (Herceptin) is a monoclonal antibody that interferes with the ..... Her-2: the making of Herceptin, a revolutionary treatment for breast cancer. ...
http://en.wikipedia.org/wiki/Trastuzumab...

Genentech: Medicines: Herceptin
Herceptin is the approved antibody for the treatment of metastatic breast cancer for patients whose tumors overexpress the HER2 protein and who have not ...
http://www.gene.com/gene/products/information/oncology/herce...

Roche - Herceptin provides impressive survival benefit for ...
24 Sep 2009 ... Overall survival for patients with high levels of HER2 receiving Herceptin was 16 months on average versus 11.8 months for patients ...
http://www.roche.com/media/media_releases/med-cor-2009-09-24...

Herceptin (R) Combined With Chemotherapy Improves Disease-Free ...
25 Apr 2005 ... Herceptin® Combined With Chemotherapy Improves Disease–Free Survival for Patients With Early–Stage Breast Cancer ...
http://www.nih.gov/news/pr/apr2005/nci-25.htm...

Genentech: Investors: Herceptin - Historical Sales
Skip to Content for Herceptin - Historical Sales Menu for Herceptin - Historical Sales About Us Menu Research Menu Development Menu Medicines Menu Investors ...
http://www.gene.com/gene/ir/financials/historical/herceptin....

Roche - Herceptin proven to benefit women with HER2 positive early ...
11 Mar 2009 ... The patients were treated for one year with Herceptin and followed up for four years. These data from the HERA study were presented at the ...
http://www.roche.com/media/media_releases/med-cor-2009-03-11...

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not ...
Herceptin safely and effectively. See full prescribing information for ..... Adverse reactions requiring interruption or discontinuation of Herceptin ...
http://www.gene.com/gene/products/information/pdf/herceptin-...

Herceptin-induced inhibition of phosphatidylinositol-3 kinase and ...
Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor action.
...
http://www.ncbi.nlm.nih.gov/pubmed/12124352...

Questions and Answers About NCI's Research With Herceptin® - 10/07 ...
Herceptin (Trastuzumab) is a monoclonal antibody, one of a group of drugs designed to attack specific cancer cells. Herceptin's targets are cancer cells
...
http://www.nih.gov/news/pr/oct98/nci-07.htm...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.